One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride

doi:10.19803/j.1672-8629.2019.12.13

Abstract

CLC Number:

R994.11

QU Gguanghong, LI Jinfeng, LI Fengjun, ZHANG Yuan. One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride[J]. Chinese Journal of Pharmacovigilance, 2019, 16(12): 765-766.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.2019.12.13

https://zgywjj.magtechjournal.com/EN/Y2019/V16/I12/765

[1] 贺璐,王国鹏,彭哲,等译.耳鸣临床应用指南[J].听力学及言语疾病杂志, 2015, 23(2):116-139.
[2] 邬丹莲,陈志高,窦文琴.45例莫西沙星不良反应病例分析[J].中国药物警戒, 2013, 13(1):42-44.
[3] FDA. Will you have Tinnitus with Moxifloxacin hydrochloride from FDA reports[EB/OL]. (2019-01-10)[2019-02-10].https://www.ehealthme.com/ds/moxifloxacin-hydrochloride/tinnitus/
[4] Onoh A, Linnebur SA, Fixen DR.Moxifloxacin-induced tinnitus in an older adult[J],Ther Adv Drug Saf. 2018,9(4):219-221.
[5] 廖日洪. 盐酸莫西沙星(拜复乐)致耳鸣1例[J].临床肺科杂志,2009, 14(3):414.
[6] 周丽华,许红蕾.莫西沙星注射液致耳鸣、听力下降、视力模糊不良反应1例[J].药物流行病学杂志, 2016,25(2):129-130.
[7] 黄月莹,高欣涛,刘弘.盐酸莫西沙星注射液致听力、视力损伤1例[J].中国药师, 2016, 19(2):334.
[8] 赵生俊,范芳芳.莫西沙星致不良反应2例[J].中国新药与临床杂志, 2009, 28(6):467-468.
[9] Guitton M J, Caston J, Ruel J,et al.Salicylate induces tinnitus through activation of cochlear NMDA receptors[J]. J Neurosci,2003, 23(9):3944-3952.
[10] Guitton M J, Dudai Y.Blockade of cochlear NMDA receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma[J]. Neural Plast, 2007,2007:80904.
[11] Eggermont J J.Pathophysiology of tinnitus. an excellent summary of current knowledge about the neural correlates of tinnitus[J]. Prog Brain Res, 2007(166):19-35.
[12] Ball P.Adverse drug reactions:implications for the development of fluoroquinolones[J]. J Antimierob Chemother,2003, 51(11):21-27.
[13] 刘辉,孙锋钢.盐酸莫西沙星导致视幻觉[J].药物不良反应杂志, 2008,10(2):141-142.
[14] 周冰,张俊,张黎明. 93例莫西沙星致严重不良反应报告分析[J].中国药物警戒, 2011, 8(11):696-698.

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.

One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics